3
Announcements
Trials
Browse
Landscape
Phase
Phase 4
1
Status
Completed
1
Sponsor Class
OTHER
1
INDUSTRY
1
Study Type
Interventional
1
Sponsor
Cancer Type
Thoracic
1
Conditions
Prostatic Neoplasms
24
Breast Neoplasms
22
Multiple Myeloma
11
Neoplasm Metastasis
9
Pain
8
Neoplasms
5
Carcinoma, Non-Small-Cell Lung
5
Bone Neoplasms
5
Osteoporosis
4
Fractures, Bone
4
Bone Diseases
4
Lung Neoplasms
3
Bone Diseases, Metabolic
3
Spinal Cord Compression
2
Humoral Hypercalcemia Of Malignancy
2
Treatment of Bone Metastases
1
Small Cell Lung Carcinoma
1
Renal Insufficiency
1
Pleural Effusion, Malignant
1
Paraproteinemias
1
Neoplastic Processes
1
Neoplastic Cells, Circulating
1
Neoplasms, Plasma Cell
1
Neoplasm, Residual
1
Lymphoma
1
Imaging Examination Shows at Least One Site With Bone Metastases From Soild Tumors
1
Hematologic Neoplasms
1
Hematologic Diseases
1
Disease Progression
1
Carcinoma, Renal Cell
1
Interventions
Cisplatin
4
Carboplatin
2
viscum album peptide
1
sugemalimab
1
rilotumumab
1
ganitumab
1
endostar protein
1
Zoledronic Acid
1
Valacyclovir
1
Thiostrepton
1
Surgical Procedures, Operative
1
Paclitaxel
1
N-(5-(2,3-dihydrobenzofuryl)sulfonyl)-N'-(3,4-dichlorophenyl)urea
1
Etoposide
1
Darbepoetin alfa
1
Cetuximab
1
Catheters, Indwelling
1
Bevacizumab
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
INDUSTRY
×
Pleural Effusion, Malignant
×
Zoledronic Acid
×
Clear all
NCT00099541
2009-11-23
Non-small Cell Lung Cancer Registry
Novartis
Phase 4
Completed
300 enrolled